Different immune responses to UV-B-treated or -untreated donor spleen cells via portal vein administration.
Yu
S
S
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
Roland
C R
CR
Goss
J A
JA
Nakafusa
Y
Y
Hafenrichter
D
D
Flye
M W
MW
D000818:Animals; D006082:Graft Enhancement, Immunologic; D006084:Graft Rejection / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology / Q000528:radiation effects*; D016027:Heart Transplantation / Q000276:immunology*; D007376:Interleukin-2 / Q000502:physiology; D007519:Isoantigens / Q000276:immunology; D007959:Lymphocyte Culture Test, Mixed; D011169:Portal Vein; D051381:Rats; D013154:Spleen / Q000276:immunology / Q000528:radiation effects / Q000637:transplantation*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D016042:Transplantation, Heterotopic / Q000276:immunology*; D014466:Ultraviolet Rays
D007376:Interleukin-2; D007519:Isoantigens